Expertise in
34
conditions

Dr. Michael J. Germain

Internal Medicine
Baystate Noble Hospital
115 W Silver St, 
Westfield, MA 
Accepting New Patients
Expertise in
34
conditions
Baystate Noble Hospital
115 W Silver St, 
Westfield, MA 

Overview

Michael Germain is a primary care provider, practicing in Internal Medicine in Westfield, Massachusetts.

Dr. Germain is highly rated in 34 conditions, according to our data. His clinical expertise encompasses Chronic Kidney Disease, Acute Kidney Failure, End-Stage Renal Disease (ESRD), Congenital Nephrotic Syndrome, and Kidney Transplant.

He is actively involved in clinical research, co-authoring 74 peer reviewed articles and participating in 9 clinical trials. Dr. Germain is currently accepting new patients.

Specialties

Internal Medicine

Licenses

Internal Medicine in MA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BMC HealthNet
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health New England
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Baystate Noble Hospital
115 W Silver St, Westfield, MA 01085

Additional Areas of Focus

Dr. Germain has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Effects of Prebiotic Supplementation and Exercise on Inflammatory Markers, Vascular Function, Cognition, and Mental Well-being in Pre-Dialysis Kidney Patients
Effects of Prebiotic Supplementation and Exercise on Inflammatory Markers, Vascular Function, Cognition, and Mental Well-being in Pre-Dialysis Kidney Patients
Enrollment Status: Completed
Publish Date: April 24, 2026
Intervention Type: Behavioral, Dietary supplement
Study Phase: Not Applicable
An Intensive Lifestyle Intervention Program in CKD (Move to Health 2)
An Intensive Lifestyle Intervention Program in CKD (Move to Health 2)
Enrollment Status: Completed
Publish Date: April 24, 2026
Intervention Type: Behavioral
Study Phase: Not Applicable
A Randomized, Multicenter, Double-blind, Parallel, Active-control Study of the Effects of Sparsentan, a Dual Endothelin Receptor and Angiotensin Receptor Blocker, on Renal Outcomes in Patients With Primary FSGS
A Randomized, Multicenter, Double-blind, Parallel, Active-control Study of the Effects of Sparsentan, a Dual Endothelin Receptor and Angiotensin Receptor Blocker, on Renal Outcomes in Patients With Primary FSGS
Enrollment Status: Completed
Publish Date: April 17, 2026
Intervention Type: Drug
Study Drugs: Sparsentan, Irbesartan
Study Phase: Phase 3
A Multi-Center, Randomized, Two-Cohort Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of CTAP101 (Calcifediol) Extended-Release Capsules to Treat Secondary Hyperparathyroidism in Subjects With Vitamin D Insufficiency and Chronic Kidney Disease Requiring Regular Hemodialysis.
A Multi-Center, Randomized, Two-Cohort Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of CTAP101 (Calcifediol) Extended-Release Capsules to Treat Secondary Hyperparathyroidism in Subjects With Vitamin D Insufficiency and Chronic Kidney Disease Requiring Regular Hemodialysis.
Enrollment Status: Terminated
Publish Date: April 03, 2026
Intervention Type: Drug
Study Drug: Calcifediol
Study Phase: Phase 2
A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
Enrollment Status: Completed
Publish Date: March 20, 2026
Intervention Type: Other, Biological
A Phase 3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Autosomal Dominant Polycystic Kidney Disease
A Phase 3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Autosomal Dominant Polycystic Kidney Disease
Enrollment Status: Terminated
Publish Date: June 03, 2025
Intervention Type: Drug
Study Drug: Bardoxolone
Study Phase: Phase 3
The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive)
The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive)
Enrollment Status: Active_not_recruiting
Publish Date: August 06, 2024
Intervention Type: Diagnostic test
A Multicenter, Open-Label, Efficacy and Safety Study of Pegloticase in Patients With Uncontrolled Gout Who Have Undergone Kidney Transplantation
A Multicenter, Open-Label, Efficacy and Safety Study of Pegloticase in Patients With Uncontrolled Gout Who Have Undergone Kidney Transplantation
Enrollment Status: Completed
Publish Date: June 26, 2024
Intervention Type: Biological
Study Drug: Pegloticase
Study Phase: Phase 4
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Enrollment Status: Completed
Publish Date: December 29, 2020
Intervention Type: Drug
Study Phase: Phase 4
View 8 Less Clinical Trials

74 Total Publications

Muscle strength, neuromuscular function, and functional measures across stages of chronic kidney disease.
Muscle strength, neuromuscular function, and functional measures across stages of chronic kidney disease.
Journal: BMC nephrology
Published: December 24, 2024
Similar Doctors
Expertise in
24
conditions
Dr. Pramod K. Mistry
Internal Medicine
Expertise in
24
conditions
Dr. Pramod K. Mistry
Internal Medicine

Radiology And Biomedical Imaging-New Haven-Yale Physicians Building

800 Howard Ave, 
New Haven, CT 
 (57.1 miles away)
203-785-7352
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Pramod Mistry is a primary care provider, practicing in Internal Medicine in New Haven, Connecticut. Dr. Mistry is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Gaucher Disease Type 1, Gaucher Disease, Gaucher Disease Type 3, Splenomegaly, and Splenectomy.

Expertise in
26
conditions
Dr. Harlan M. Krumholz
Internal Medicine
Expertise in
26
conditions
Dr. Harlan M. Krumholz
Internal Medicine

Office

1 Church St Ste 200, 
New Haven, CT 
 (56.7 miles away)
203-764-5885
Languages Spoken:
English
See accepted insurances

Harlan Krumholz is a primary care provider, practicing in Internal Medicine in New Haven, Connecticut. Dr. Krumholz is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Heart Attack, Heart Failure, Pulmonary Embolism, Percutaneous Coronary Intervention (PCI), and Coronary Artery Bypass Graft (CABG).

Expertise in
6
conditions
Dr. Peter K. Lindenauer
Internal Medicine
Expertise in
6
conditions
Dr. Peter K. Lindenauer
Internal Medicine

Office

3601 Main St, 
Springfield, MA 
 (7.6 miles away)
413-794-5987
Languages Spoken:
English

Peter Lindenauer is a primary care provider, practicing in Internal Medicine in Springfield, Massachusetts. Dr. Lindenauer is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Pneumonia, Chronic Obstructive Pulmonary Disease (COPD), Hospital-Acquired Pneumonia, and Heart Failure.

Frequently Asked Questions about Dr. Michael J. Germain

How do I make an appointment with Dr. Michael J. Germain?

You can book an appointment with Dr. Michael J. Germain by calling their office at 413-733-9666. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Michael J. Germain a top-rated expert for Chronic Kidney Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michael J. Germain is classified as an Elite expert for Chronic Kidney Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Michael J. Germain specialize in?

While Dr. Michael J. Germain is a Internal Medicine, they have specific expertise in Chronic Kidney Disease, Acute Kidney Failure, and End-Stage Renal Disease (ESRD). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Michael J. Germain participate in research or clinical trials?

Yes. Dr. Michael J. Germain has published 74 articles and abstracts on conditions like Chronic Kidney Disease. You can view a list of Dr. Michael J. Germain's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Michael J. Germain accept my insurance?

Dr. Michael J. Germain accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 413-733-9666 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Germain's expertise for a condition
ConditionClose
View All 29 Advanced Conditions
View All 65 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile